A pilot study on the use of topical tazarotene to treat squamous cell carcinoma in situ [4]

Journal of the American Academy of Dermatology

Volumn 52, Issue 6, 2005, Pages 1102-1104

  Bardazzi, Federico ^a   Bianchi, Federica ^a   Parente, Gianluca ^a   Guareschi, Elisa ^a   Landi, Christian ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TAZAROTENE;

ADULT; AGED; CANCER RECURRENCE; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; ERYTHEMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INFORMED CONSENT; LETTER; MALE; PATIENT COMPLIANCE; PATIENT INFORMATION; PRIORITY JOURNAL; SAMPLE SIZE; SKIN IRRITATION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; TREATMENT WITHDRAWAL; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 19544367609     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.07.003     Document Type: Article

References (5)

1. K. Peris, M.C. Fargnoli, and S. Chimenti Preliminary observations on the use of the topical tazarotene to treat basal-cell carcinoma N Engl J Med 341 1999 1767 1768
2. H.K. Bell, and L.E. Rhodes Bowen's disease-a retrospective review of clinical management Clin Exp Dermatol 24 1999 338 339
3. K.J. Smith, M. Germain, and H. Skelton Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy Dermatol Surg 27 2001 561 564
4. B. Ofmann, H. Stege, T. Ruzicka, and P. Lehmann Effect of topical tazarotene in the treatment of congenital ichthyoses Br J Dermatol 141 1999 642 646
5. L.N. Wei Retinod receptors and their coregulators Annu Rev Pharmacol Toxicol 24 2002 47 72